TREATMENT SETTINGS
A selected treatment sepng with the Vibralung AcousEcal Percussor takes up to 10 minutes, depending upon the
sepng that has been selected, and provided the session has not been paused at any Eme.
Five sepngs, represenEng a designated sequence of frequency ranges, have been programmed into the
Treatment
Control Unit as shown in the following table:
A treatment session may consist of the applicaEon of one or more sepngs, depending upon the target area(s) of the
lungs to which therapy should be directed, paEent preference and paEent response to therapy. In theory, lower
frequency tones are effecEve on larger, wider airways while higher frequency tones are effecEve on smaller, thinner
airways. TherapeuEc benefit(s) may not necessarily be rendered on the first treatment, or even the first few
treatments. It may require an indeterminate number of treatment sessions, 2 to 4 Emes daily, before benefits become
apparent.
SIMULTANEOUS AEROSOL THERAPY
The Circulaire II
Hybrid
aerosol delivery system may be used with the Vibralung AcousEcal Percussor if wepng agents
or inhalaEon medicaEons are prescribed. The Circulaire II
Hybrid
is the only nebulizer system approved for use with
the Vibralung AcousEcal Percussor. The Vibralung includes an Aerosol Y-‐adapter that allows connecEng the Circulaire
II
Hybrid
to the HHT, as shown in the boYom figure on page 4.
The Circulaire II
Hybrid
, when aYached to the Vibralung AcousEcal Percussor with the Aerosol Y-‐adapter, provides a
direct pathway for inhalaEon and exhalaEon. The Aerosol Y-‐adapter provides a direct pathway for the sound waves to
travel through to enter the mouth and the lung. In this manner, the acousEcal energy remains coupled to the
paEent’s lungs during inhalaEon and exhalaEon while the aerosol treatment is taking place.
Further, PEP therapy can also be administered by way of the Circulaire II
Hybrid
, which has a Variable Expiratory
Resistor on the exhalaEon port. Finally, because many of the paEents who may benefit from airway clearance therapy
and aerosol therapy with the Vibralung AcousEcal Percussor also have pulmonary infecEons, an exhalaEon filter is
included in the exhalaEon pathway of the Circulaire II
Hybrid
to prevent medicaEons and paEent droplets from being
emiYed into the room and possibly inhaled by caregivers or other paEents.
Page 7
WARNING -‐ Do not connect or interface the Vibralung Acous(cal Percussor to any airway clearance
device or aerosol delivery system other than the Westmed Circulaire® II or Circulaire II
Hybrid
™
aerosol drug delivery system and/or Westmed Variable Expiratory Resistor for Posi(ve Expiratory
Pressure (PEP) because other devices have not been designed or ascertained to func(on properly
with the inspiratory and exhala(on gas flow pathways of the Vibralung.
